BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15202943)

  • 1. A two-dimensional mathematical model of percutaneous drug absorption.
    George K; Kubota K; Twizell EH
    Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
    Simon L; Ospina J
    Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
    Simon L; Loney NW
    Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lag time in the dual sorption model for percutaneous absorption with finite skin-receptor boundary clearance.
    Twizell EH; Kubota K
    Math Biosci; 1994 Sep; 123(1):1-23. PubMed ID: 7949743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
    Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
    Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
    Zghoul N; Fuchs R; Lehr CM; Schaefer UF
    ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonlinear numerical model of percutaneous drug absorption.
    Kubota K; Twizell EH
    Math Biosci; 1992 Mar; 108(2):157-78. PubMed ID: 1547360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfacial kinetics effects on transdermal drug delivery: a computer modeling.
    Xing MM; Pan N; Zhong W; Hui X; Maibach HI
    Skin Res Technol; 2008 May; 14(2):165-72. PubMed ID: 18412558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global extrapolation of numerical methods for computing concentration profiles in percutaneous drug absorption.
    Twizell EH
    Comput Biol Med; 1989; 19(3):163-71. PubMed ID: 2721162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of blood flow on near-the-wall mass transport of drugs and other bioactive agents: a simple formula to estimate boundary layer concentrations.
    Rugonyi S
    J Biomech Eng; 2008 Apr; 130(2):021010. PubMed ID: 18412497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
    Fasano WJ; McDougal JN
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finite element modeling of coupled diffusion with partitioning in transdermal drug delivery.
    Rim JE; Pinsky PM; van Osdol WW
    Ann Biomed Eng; 2005 Oct; 33(10):1422-38. PubMed ID: 16240090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finite dose percutaneous drug absorption: a BASIC program for the solution of the diffusion equation.
    Kubota K
    Comput Biomed Res; 1991 Apr; 24(2):196-207. PubMed ID: 1903685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diffusion-diffusion model for percutaneous drug absorption.
    Kubota K; Ishizaki T
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):409-39. PubMed ID: 3772740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a new dosimetry program TAOCS to assess transient vapour absorption in the upper airways.
    Tian G; Longest PW
    Inhal Toxicol; 2010 Nov; 22(13):1047-63. PubMed ID: 21070181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spreadsheet-based method for estimating the skin disposition of volatile compounds: application to N,N-diethyl-m-toluamide (DEET).
    Kasting GB; Miller MA; Bhatt VD
    J Occup Environ Hyg; 2008 Oct; 5(10):633-44. PubMed ID: 18668403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated applications of a transdermal patch: analytical solution and optimal control of the delivery rate.
    Simon L
    Math Biosci; 2007 Oct; 209(2):593-607. PubMed ID: 17490691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.